MeVis Medical Solutions AGFRA:M3V 66 Net Margin % is 7.91% as of Mar. 2026, which is 75% below its 10-year median of 31.81. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 75.15% on this metric.
The historical rank and industry rank for MeVis Medical Solutions AG's Net Margin % or its related term are showing as below:
FRA:M3V'
s Net Margin % Range Over the Past 10 Years
Min: 8.94 Med: 31.81 Max: 44.66
Current: 8.94
FRA:M3V's Net Margin % is ranked better than 75.15% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs FRA:M3V: 8.94
MeVis Medical Solutions AG (FRA:M3V) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
MeVis Medical Solutions AG Net Margin % Related Terms
MeVis Medical Solutions AG Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Net Margin % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a Net Margin % of 7.91% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on MeVis Medical Solutions AG and its competitors. This is 75% below median its historical median of 31.81. Over the past decade, MeVis Medical Solutions AG's Net Margin % has ranged from 8.94 to 44.66. According to the industry distribution chart, MeVis Medical Solutions AG ranks #166 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 24.9%.
Is MeVis Medical Solutions AG's Net Margin % too high?
MeVis Medical Solutions AG's current Net Margin % of 7.91% is 75% below median its 10-year median of 31.81. Over the past 10 years, this metric has ranged from a low of 8.94 to a high of 44.66. The Healthcare Providers & Services industry median Net Margin % is 2.89. MeVis Medical Solutions AG's value of 7.91% is 174.2% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #166 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #166 out of 668 companies for Net Margin %. This places MeVis Medical Solutions AG in the top 25% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. MeVis Medical Solutions AG's value of 7.91% is 174.2% above this benchmark. Historically, MeVis Medical Solutions AG's own Net Margin % has ranged from 8.94 to 44.66 over the past decade. While the company's 10-year median is 31.81 vs. the industry median of 2.89, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Net Margin % of 7.91% is 174.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Net Margin % is 7.91%, which is 75% below median its own 10-year median of 31.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Net Margin % of 7.91%. The stock's GF Value™ is €22.52, compared to a current price of €23.20 — trading 3% above its estimated fair value. The current Net Margin % is 7.91%, which is 75% below median its 10-year median of 31.81 and 174.2% above the Healthcare Providers & Services industry median of 2.89. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Net Margin % is 7.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.20 is trading 3% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Net Margin %: 7.91% (75% below median its 10-year median of 31.81)
GF Value™: €22.52 vs. price of €23.20 (3% above fair value)
Industry Position: 174.2% above the Healthcare Providers & Services median (#166 of 668)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
